Ovoca Bio falls on delayed results for low sexual drive disorder treatment
12/06/2023 08:51
** Shares of UK-listed Ovoca Bio OVB.L down 12.9% at 6.75p
** OVB set for biggest one-day value loss in nearly 9 months
** Australian Contract Research Organisation (CRO) delays
timeline for delivering results of mid-stage study assessing
treatment for women with low sexual drive disorder
** CRO says results delayed due to issues with staffing
levels
** Results now expected to be finalised in August, compared
to previously expected time frame of June
** Staffing issues resolved, efforts being made to expedite
completion of study, co adds
** As of last close, stock up 58.8% this year
(Reporting by Richard Rohan Francis in Bengaluru)
((Richardrohan.francis@thomsonreuters.com))